nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGS2—bile duct cancer	0.686	1	CbGaD
Indomethacin—SLC10A1—bile duct—bile duct cancer	0.0343	0.156	CbGeAlD
Indomethacin—SLC10A1—bile—bile duct cancer	0.0264	0.12	CbGeAlD
Indomethacin—ABCC3—bile duct—bile duct cancer	0.0216	0.0981	CbGeAlD
Indomethacin—ABCC2—bile duct—bile duct cancer	0.0172	0.0784	CbGeAlD
Indomethacin—ABCC2—bile—bile duct cancer	0.0132	0.0602	CbGeAlD
Indomethacin—CES1—gall bladder—bile duct cancer	0.00565	0.0257	CbGeAlD
Indomethacin—ABCC3—gall bladder—bile duct cancer	0.0046	0.0209	CbGeAlD
Indomethacin—PTGR2—liver—bile duct cancer	0.00416	0.0189	CbGeAlD
Indomethacin—ABCC11—liver—bile duct cancer	0.00412	0.0187	CbGeAlD
Indomethacin—GLO1—pancreas—bile duct cancer	0.00404	0.0184	CbGeAlD
Indomethacin—ALB—gall bladder—bile duct cancer	0.00392	0.0178	CbGeAlD
Indomethacin—PLA2G2A—pancreas—bile duct cancer	0.00375	0.0171	CbGeAlD
Indomethacin—CXCL8—pancreas—bile duct cancer	0.00372	0.0169	CbGeAlD
Indomethacin—PPARA—pancreas—bile duct cancer	0.00351	0.0159	CbGeAlD
Indomethacin—PTGR2—lymph node—bile duct cancer	0.00319	0.0145	CbGeAlD
Indomethacin—Bromfenac—PTGS2—bile duct cancer	0.003	0.459	CrCbGaD
Indomethacin—AKR1C3—pancreas—bile duct cancer	0.00291	0.0132	CbGeAlD
Indomethacin—GLO1—liver—bile duct cancer	0.00257	0.0117	CbGeAlD
Indomethacin—UGT1A9—liver—bile duct cancer	0.00249	0.0113	CbGeAlD
Indomethacin—PLA2G2A—liver—bile duct cancer	0.00239	0.0109	CbGeAlD
Indomethacin—ABCC6—liver—bile duct cancer	0.00236	0.0107	CbGeAlD
Indomethacin—CXCL8—liver—bile duct cancer	0.00236	0.0107	CbGeAlD
Indomethacin—PPARA—liver—bile duct cancer	0.00223	0.0101	CbGeAlD
Indomethacin—SLC10A1—liver—bile duct cancer	0.00215	0.00975	CbGeAlD
Indomethacin—PTGS2—gall bladder—bile duct cancer	0.00214	0.00972	CbGeAlD
Indomethacin—Tolmetin—PTGS2—bile duct cancer	0.00201	0.309	CrCbGaD
Indomethacin—UGT2B7—liver—bile duct cancer	0.00201	0.00914	CbGeAlD
Indomethacin—GLO1—lymph node—bile duct cancer	0.00197	0.00895	CbGeAlD
Indomethacin—SLC22A11—liver—bile duct cancer	0.00196	0.0089	CbGeAlD
Indomethacin—PPARG—pancreas—bile duct cancer	0.00193	0.00876	CbGeAlD
Indomethacin—SLC22A7—liver—bile duct cancer	0.00191	0.00869	CbGeAlD
Indomethacin—AKR1C3—liver—bile duct cancer	0.00185	0.00842	CbGeAlD
Indomethacin—PLA2G2A—lymph node—bile duct cancer	0.00183	0.00832	CbGeAlD
Indomethacin—CXCL8—lymph node—bile duct cancer	0.00181	0.00824	CbGeAlD
Indomethacin—ABCC4—pancreas—bile duct cancer	0.00175	0.00796	CbGeAlD
Indomethacin—PPARA—lymph node—bile duct cancer	0.00171	0.00777	CbGeAlD
Indomethacin—UGT1A1—liver—bile duct cancer	0.00171	0.00777	CbGeAlD
Indomethacin—CES1—liver—bile duct cancer	0.00166	0.00752	CbGeAlD
Indomethacin—Naproxen—PTGS2—bile duct cancer	0.00151	0.232	CrCbGaD
Indomethacin—SLCO1B1—liver—bile duct cancer	0.00142	0.00646	CbGeAlD
Indomethacin—AKR1C3—lymph node—bile duct cancer	0.00142	0.00646	CbGeAlD
Indomethacin—ABCC3—liver—bile duct cancer	0.00135	0.00613	CbGeAlD
Indomethacin—CES1—lymph node—bile duct cancer	0.00127	0.00577	CbGeAlD
Indomethacin—PPARG—liver—bile duct cancer	0.00123	0.00558	CbGeAlD
Indomethacin—SLCO1A2—liver—bile duct cancer	0.00116	0.00526	CbGeAlD
Indomethacin—ALB—liver—bile duct cancer	0.00115	0.00523	CbGeAlD
Indomethacin—ABCC4—liver—bile duct cancer	0.00111	0.00506	CbGeAlD
Indomethacin—ABCC2—liver—bile duct cancer	0.00108	0.0049	CbGeAlD
Indomethacin—ABCC3—lymph node—bile duct cancer	0.00103	0.0047	CbGeAlD
Indomethacin—PTGS2—pancreas—bile duct cancer	0.000985	0.00448	CbGeAlD
Indomethacin—ABCC1—liver—bile duct cancer	0.00095	0.00432	CbGeAlD
Indomethacin—PPARG—lymph node—bile duct cancer	0.00094	0.00427	CbGeAlD
Indomethacin—CYP2C19—liver—bile duct cancer	0.000926	0.00421	CbGeAlD
Indomethacin—ALB—lymph node—bile duct cancer	0.000882	0.00401	CbGeAlD
Indomethacin—ABCC4—lymph node—bile duct cancer	0.000854	0.00388	CbGeAlD
Indomethacin—ABCC2—lymph node—bile duct cancer	0.000827	0.00376	CbGeAlD
Indomethacin—ABCC1—lymph node—bile duct cancer	0.000728	0.00331	CbGeAlD
Indomethacin—CYP2C9—liver—bile duct cancer	0.000718	0.00327	CbGeAlD
Indomethacin—PTGS2—liver—bile duct cancer	0.000627	0.00285	CbGeAlD
Indomethacin—ABCB1—pancreas—bile duct cancer	0.000609	0.00277	CbGeAlD
Indomethacin—PTGS1—lymph node—bile duct cancer	0.000503	0.00229	CbGeAlD
Indomethacin—PTGS2—lymph node—bile duct cancer	0.000481	0.00218	CbGeAlD
Indomethacin—ABCB1—liver—bile duct cancer	0.000388	0.00176	CbGeAlD
Indomethacin—ABCB1—lymph node—bile duct cancer	0.000297	0.00135	CbGeAlD
Indomethacin—AKR1C3—Metabolism—SLC5A5—bile duct cancer	8.39e-05	0.000957	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	8.39e-05	0.000957	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—IDH1—bile duct cancer	8.35e-05	0.000953	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—IDH1—bile duct cancer	8.35e-05	0.000953	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	8.3e-05	0.000947	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	8.3e-05	0.000946	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—IL6—bile duct cancer	8.26e-05	0.000942	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	8.24e-05	0.00094	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFBR2—bile duct cancer	8.07e-05	0.00092	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—GNAS—bile duct cancer	8.01e-05	0.000914	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	7.98e-05	0.00091	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	7.96e-05	0.000908	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—IDH1—bile duct cancer	7.9e-05	0.000901	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—IDH2—bile duct cancer	7.89e-05	0.0009	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—IDH2—bile duct cancer	7.89e-05	0.0009	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.86e-05	0.000896	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IDH1—bile duct cancer	7.82e-05	0.000891	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—NRAS—bile duct cancer	7.8e-05	0.00089	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—ERBB2—bile duct cancer	7.8e-05	0.00089	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MET—bile duct cancer	7.65e-05	0.000873	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SMAD4—bile duct cancer	7.64e-05	0.000871	CbGpPWpGaD
Indomethacin—ALB—Platelet degranulation—TGFB1—bile duct cancer	7.63e-05	0.00087	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—IDH2—bile duct cancer	7.61e-05	0.000868	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—FAR2—bile duct cancer	7.6e-05	0.000867	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—GNAS—bile duct cancer	7.58e-05	0.000864	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	7.48e-05	0.000854	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	7.48e-05	0.000853	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—FAR2—bile duct cancer	7.41e-05	0.000846	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TP53—bile duct cancer	7.33e-05	0.000836	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—GNAS—bile duct cancer	7.28e-05	0.00083	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—IDH1—bile duct cancer	7.27e-05	0.00083	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—SLC5A5—bile duct cancer	7.27e-05	0.000829	CbGpPWpGaD
Indomethacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	7.27e-05	0.000829	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NOS2—bile duct cancer	7.25e-05	0.000827	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	7.25e-05	0.000827	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—IDH2—bile duct cancer	7.23e-05	0.000825	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—GNAS—bile duct cancer	7.16e-05	0.000817	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	7.16e-05	0.000817	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	7.14e-05	0.000815	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—SMAD4—bile duct cancer	7.13e-05	0.000813	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—EGFR—bile duct cancer	7.11e-05	0.000811	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—FAR2—bile duct cancer	6.93e-05	0.00079	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	6.91e-05	0.000788	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—bile duct cancer	6.82e-05	0.000778	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	6.81e-05	0.000777	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.81e-05	0.000777	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—IDH1—bile duct cancer	6.79e-05	0.000774	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—IDH1—bile duct cancer	6.79e-05	0.000774	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	6.78e-05	0.000773	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	6.75e-05	0.00077	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—KRAS—bile duct cancer	6.72e-05	0.000766	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL6—bile duct cancer	6.71e-05	0.000765	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MMP9—bile duct cancer	6.69e-05	0.000763	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—bile duct cancer	6.68e-05	0.000762	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	6.65e-05	0.000759	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	6.59e-05	0.000751	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—IDH1—bile duct cancer	6.55e-05	0.000747	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	6.53e-05	0.000745	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GNAS—bile duct cancer	6.52e-05	0.000743	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—IDH2—bile duct cancer	6.43e-05	0.000734	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP2—bile duct cancer	6.38e-05	0.000728	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—MMP2—bile duct cancer	6.25e-05	0.000713	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—IL6—bile duct cancer	6.24e-05	0.000712	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—IDH1—bile duct cancer	6.22e-05	0.000709	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—IL6—bile duct cancer	6.12e-05	0.000698	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RNF43—bile duct cancer	6.1e-05	0.000696	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—ERBB2—bile duct cancer	6.06e-05	0.000691	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—NRAS—bile duct cancer	5.94e-05	0.000677	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HRAS—bile duct cancer	5.71e-05	0.000651	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	5.69e-05	0.000649	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NOS2—bile duct cancer	5.68e-05	0.000648	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GNAS—bile duct cancer	5.65e-05	0.000645	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFBR2—bile duct cancer	5.65e-05	0.000644	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—ERBB2—bile duct cancer	5.59e-05	0.000638	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—IDH1—bile duct cancer	5.53e-05	0.000631	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TGFB1—bile duct cancer	5.52e-05	0.000629	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—SLC5A5—bile duct cancer	5.51e-05	0.000629	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—SLC5A5—bile duct cancer	5.51e-05	0.000629	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL6—bile duct cancer	5.46e-05	0.000623	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—GNAS—bile duct cancer	5.45e-05	0.000622	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—EGFR—bile duct cancer	5.41e-05	0.000617	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SMAD4—bile duct cancer	5.35e-05	0.00061	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	5.33e-05	0.000608	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IDH1—bile duct cancer	5.25e-05	0.000598	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—SLC5A5—bile duct cancer	5.21e-05	0.000594	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	5.21e-05	0.000594	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MMP9—bile duct cancer	5.2e-05	0.000593	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	5.16e-05	0.000589	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—SMAD4—bile duct cancer	5.11e-05	0.000583	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—KRAS—bile duct cancer	5.11e-05	0.000583	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—IDH2—bile duct cancer	5.11e-05	0.000583	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	5.01e-05	0.000571	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.88e-05	0.000557	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—SLC5A5—bile duct cancer	4.8e-05	0.000547	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP9—bile duct cancer	4.8e-05	0.000547	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTGS2—bile duct cancer	4.79e-05	0.000546	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	4.71e-05	0.000538	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	4.7e-05	0.000536	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NRAS—bile duct cancer	4.61e-05	0.000526	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	4.61e-05	0.000526	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	4.61e-05	0.000526	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.5e-05	0.000513	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—GNAS—bile duct cancer	4.49e-05	0.000513	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—SLC5A5—bile duct cancer	4.48e-05	0.000511	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—SLC5A5—bile duct cancer	4.48e-05	0.000511	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFBR2—bile duct cancer	4.46e-05	0.000508	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—IDH1—bile duct cancer	4.39e-05	0.000501	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	4.39e-05	0.0005	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	4.36e-05	0.000497	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—HRAS—bile duct cancer	4.34e-05	0.000495	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SLC5A5—bile duct cancer	4.32e-05	0.000493	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GNAS—bile duct cancer	4.3e-05	0.00049	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TGFB1—bile duct cancer	4.28e-05	0.000489	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GNAS—bile duct cancer	4.28e-05	0.000488	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GNAS—bile duct cancer	4.28e-05	0.000488	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HGF—bile duct cancer	4.28e-05	0.000488	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—ERBB2—bile duct cancer	4.27e-05	0.000487	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—NRAS—bile duct cancer	4.25e-05	0.000485	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SMAD4—bile duct cancer	4.22e-05	0.000481	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EGFR—bile duct cancer	4.2e-05	0.000479	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.2e-05	0.000479	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—bile duct cancer	4.18e-05	0.000477	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—bile duct cancer	4.16e-05	0.000474	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFBR2—bile duct cancer	4.15e-05	0.000474	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NRAS—bile duct cancer	4.15e-05	0.000473	CbGpPWpGaD
Indomethacin—ALB—Metabolism—IDH2—bile duct cancer	4.13e-05	0.000471	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SLC5A5—bile duct cancer	4.1e-05	0.000468	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—bile duct cancer	4.07e-05	0.000464	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GNAS—bile duct cancer	4.05e-05	0.000462	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.05e-05	0.000462	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KRAS—bile duct cancer	3.97e-05	0.000453	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TGFB1—bile duct cancer	3.95e-05	0.000451	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SMAD4—bile duct cancer	3.93e-05	0.000448	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.89e-05	0.000444	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EGFR—bile duct cancer	3.88e-05	0.000442	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.87e-05	0.000441	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TGFB1—bile duct cancer	3.86e-05	0.00044	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	3.85e-05	0.000439	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GNAS—bile duct cancer	3.73e-05	0.000425	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—IDH2—bile duct cancer	3.71e-05	0.000423	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—KRAS—bile duct cancer	3.66e-05	0.000418	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SLC5A5—bile duct cancer	3.65e-05	0.000416	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—IDH2—bile duct cancer	3.62e-05	0.000413	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—KRAS—bile duct cancer	3.57e-05	0.000407	CbGpPWpGaD
Indomethacin—ALB—Metabolism—IDH1—bile duct cancer	3.55e-05	0.000405	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—bile duct cancer	3.53e-05	0.000402	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—bile duct cancer	3.5e-05	0.000399	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GNAS—bile duct cancer	3.48e-05	0.000397	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GNAS—bile duct cancer	3.48e-05	0.000397	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	3.42e-05	0.00039	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.41e-05	0.000389	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	3.38e-05	0.000386	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—IDH2—bile duct cancer	3.38e-05	0.000386	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—bile duct cancer	3.37e-05	0.000385	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GNAS—bile duct cancer	3.36e-05	0.000383	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	3.33e-05	0.00038	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS2—bile duct cancer	3.28e-05	0.000374	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	3.27e-05	0.000373	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—bile duct cancer	3.25e-05	0.000371	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—bile duct cancer	3.23e-05	0.000368	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—IDH1—bile duct cancer	3.19e-05	0.000364	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GNAS—bile duct cancer	3.19e-05	0.000364	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—bile duct cancer	3.17e-05	0.000362	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—IDH1—bile duct cancer	3.11e-05	0.000355	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—bile duct cancer	3.11e-05	0.000355	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.09e-05	0.000352	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—bile duct cancer	3.04e-05	0.000347	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—bile duct cancer	3.04e-05	0.000346	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—bile duct cancer	3.03e-05	0.000346	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TGFB1—bile duct cancer	3.02e-05	0.000345	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ERBB2—bile duct cancer	2.99e-05	0.000341	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—bile duct cancer	2.98e-05	0.00034	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EGFR—bile duct cancer	2.96e-05	0.000338	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS2—bile duct cancer	2.93e-05	0.000334	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—IDH1—bile duct cancer	2.91e-05	0.000332	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC5A5—bile duct cancer	2.9e-05	0.000331	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GNAS—bile duct cancer	2.84e-05	0.000324	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—bile duct cancer	2.8e-05	0.000319	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFBR2—bile duct cancer	2.79e-05	0.000318	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EGFR—bile duct cancer	2.77e-05	0.000316	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.74e-05	0.000313	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SMAD4—bile duct cancer	2.64e-05	0.000301	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—bile duct cancer	2.62e-05	0.000298	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—bile duct cancer	2.57e-05	0.000293	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—bile duct cancer	2.38e-05	0.000271	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—bile duct cancer	2.36e-05	0.000269	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC5A5—bile duct cancer	2.34e-05	0.000267	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—bile duct cancer	2.3e-05	0.000262	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—bile duct cancer	2.3e-05	0.000262	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—bile duct cancer	2.28e-05	0.00026	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—bile duct cancer	2.28e-05	0.00026	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GNAS—bile duct cancer	2.25e-05	0.000257	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—bile duct cancer	2.22e-05	0.000254	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—bile duct cancer	2.2e-05	0.000251	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.2e-05	0.000251	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—bile duct cancer	2.17e-05	0.000248	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—bile duct cancer	2.15e-05	0.000245	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—bile duct cancer	2.13e-05	0.000243	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—bile duct cancer	2.12e-05	0.000241	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC5A5—bile duct cancer	2.1e-05	0.00024	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—bile duct cancer	2.07e-05	0.000237	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC5A5—bile duct cancer	2.05e-05	0.000234	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—bile duct cancer	2.03e-05	0.000231	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—bile duct cancer	2e-05	0.000228	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.97e-05	0.000225	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—bile duct cancer	1.96e-05	0.000224	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—bile duct cancer	1.96e-05	0.000224	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—bile duct cancer	1.92e-05	0.000219	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—bile duct cancer	1.88e-05	0.000214	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—bile duct cancer	1.87e-05	0.000213	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—bile duct cancer	1.87e-05	0.000213	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GNAS—bile duct cancer	1.82e-05	0.000208	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—bile duct cancer	1.8e-05	0.000206	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.8e-05	0.000205	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—bile duct cancer	1.8e-05	0.000205	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—bile duct cancer	1.74e-05	0.000199	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—bile duct cancer	1.74e-05	0.000199	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—bile duct cancer	1.71e-05	0.000195	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—bile duct cancer	1.67e-05	0.000191	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—bile duct cancer	1.67e-05	0.00019	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—bile duct cancer	1.67e-05	0.00019	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—bile duct cancer	1.64e-05	0.000187	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNAS—bile duct cancer	1.64e-05	0.000187	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—bile duct cancer	1.62e-05	0.000184	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNAS—bile duct cancer	1.6e-05	0.000182	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—bile duct cancer	1.59e-05	0.000182	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—bile duct cancer	1.56e-05	0.000177	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—bile duct cancer	1.55e-05	0.000176	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—bile duct cancer	1.53e-05	0.000174	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—bile duct cancer	1.52e-05	0.000174	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNAS—bile duct cancer	1.49e-05	0.00017	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—bile duct cancer	1.48e-05	0.000168	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—bile duct cancer	1.44e-05	0.000164	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—bile duct cancer	1.44e-05	0.000164	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—bile duct cancer	1.37e-05	0.000157	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—bile duct cancer	1.37e-05	0.000157	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—bile duct cancer	1.31e-05	0.00015	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—bile duct cancer	1.26e-05	0.000143	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—bile duct cancer	1.22e-05	0.00014	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—bile duct cancer	1.17e-05	0.000134	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—bile duct cancer	1.12e-05	0.000128	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—bile duct cancer	1.04e-05	0.000119	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—bile duct cancer	1.02e-05	0.000117	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—bile duct cancer	9.78e-06	0.000112	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—bile duct cancer	9.67e-06	0.00011	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—bile duct cancer	8.78e-06	0.0001	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—bile duct cancer	8.57e-06	9.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—bile duct cancer	8.22e-06	9.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—bile duct cancer	8.01e-06	9.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—bile duct cancer	7.87e-06	8.97e-05	CbGpPWpGaD
